KRAS signaling-mediated T mobile receptor (TCR) signaling activation and mobile proliferation are conditions for CD8+ T perform, which may describe why lanosterol inhibits intratumoral CD8+ T mobile operate.[15] The inhibition in the PI3K/mTOR pathway is demonstrated to potently block proliferation by inducing G1 arrest in several tumor cell lines.